rs72821356

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_013275.6(ANKRD11):​c.4932G>A​(p.Gly1644Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0389 in 1,614,124 control chromosomes in the GnomAD database, including 1,585 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 153 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1432 hom. )

Consequence

ANKRD11
NM_013275.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.863

Publications

7 publications found
Variant links:
Genes affected
ANKRD11 (HGNC:21316): (ankyrin repeat domain containing 11) This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
ANKRD11 Gene-Disease associations (from GenCC):
  • KBG syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, Illumina, ClinGen
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-89281610-C-T is Benign according to our data. Variant chr16-89281610-C-T is described in ClinVar as Benign. ClinVar VariationId is 380367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.863 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0568 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD11NM_013275.6 linkc.4932G>A p.Gly1644Gly synonymous_variant Exon 9 of 13 ENST00000301030.10 NP_037407.4 Q6UB99
ANKRD11NM_001256182.2 linkc.4932G>A p.Gly1644Gly synonymous_variant Exon 10 of 14 NP_001243111.1 Q6UB99
ANKRD11NM_001256183.2 linkc.4932G>A p.Gly1644Gly synonymous_variant Exon 9 of 13 NP_001243112.1 Q6UB99

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD11ENST00000301030.10 linkc.4932G>A p.Gly1644Gly synonymous_variant Exon 9 of 13 5 NM_013275.6 ENSP00000301030.4 Q6UB99

Frequencies

GnomAD3 genomes
AF:
0.0337
AC:
5119
AN:
152118
Hom.:
153
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00722
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0246
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.0620
Gnomad SAS
AF:
0.0157
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0380
Gnomad OTH
AF:
0.0253
GnomAD2 exomes
AF:
0.0401
AC:
10063
AN:
250712
AF XY:
0.0393
show subpopulations
Gnomad AFR exome
AF:
0.00750
Gnomad AMR exome
AF:
0.0284
Gnomad ASJ exome
AF:
0.0102
Gnomad EAS exome
AF:
0.0665
Gnomad FIN exome
AF:
0.127
Gnomad NFE exome
AF:
0.0382
Gnomad OTH exome
AF:
0.0426
GnomAD4 exome
AF:
0.0395
AC:
57700
AN:
1461888
Hom.:
1432
Cov.:
35
AF XY:
0.0385
AC XY:
27975
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00621
AC:
208
AN:
33480
American (AMR)
AF:
0.0292
AC:
1305
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
287
AN:
26136
East Asian (EAS)
AF:
0.0624
AC:
2478
AN:
39700
South Asian (SAS)
AF:
0.0116
AC:
998
AN:
86258
European-Finnish (FIN)
AF:
0.122
AC:
6518
AN:
53414
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.0393
AC:
43746
AN:
1112012
Other (OTH)
AF:
0.0351
AC:
2118
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3946
7891
11837
15782
19728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1678
3356
5034
6712
8390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0336
AC:
5120
AN:
152236
Hom.:
153
Cov.:
32
AF XY:
0.0375
AC XY:
2788
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00719
AC:
299
AN:
41562
American (AMR)
AF:
0.0245
AC:
375
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00922
AC:
32
AN:
3472
East Asian (EAS)
AF:
0.0624
AC:
322
AN:
5164
South Asian (SAS)
AF:
0.0159
AC:
77
AN:
4828
European-Finnish (FIN)
AF:
0.130
AC:
1374
AN:
10598
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0380
AC:
2586
AN:
67996
Other (OTH)
AF:
0.0251
AC:
53
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
252
504
757
1009
1261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0325
Hom.:
46
Bravo
AF:
0.0251
Asia WGS
AF:
0.0410
AC:
143
AN:
3478
EpiCase
AF:
0.0306
EpiControl
AF:
0.0293

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 22, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 16, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KBG syndrome Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 19, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.46
DANN
Benign
0.20
PhyloP100
-0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72821356; hg19: chr16-89348018; COSMIC: COSV56357472; COSMIC: COSV56357472; API